Prolactinomas, dopamine agonists and headache: two case reports

被引:79
|
作者
Levy, MJ
Matharu, MS
Goadsby, PJ
机构
[1] Inst Neurol, Headache Grp, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
关键词
continua; hemicrania; indomethacin; pituitary; SUNCT;
D O I
10.1046/j.1468-1331.2003.00549.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Headache is a common problem in patients with pituitary tumours. Small pituitary lesions can cause debilitating headache, suggesting that the size of the pituitary tumour may not be the only causal factor in pituitary-related headache. We present two cases of prolactinoma-associated headache. The first case has a clinical diagnosis of short-lasting unilateral headache attacks with conjunctival injection and tearing (SUNCT). The second case has a clinical diagnosis of hemicrania continua and idiopathic stabbing headache. In each case, the administration of dopamine agonists has led to an exacerbation of symptoms. We review the relevant literature to understand the pathophysiological implications of these cases.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [1] PROLACTINOMAS AND RESISTANCE TO DOPAMINE AGONISTS
    BRUE, T
    PELLEGRINI, I
    PRIOU, A
    MORANGE, I
    JAQUET, P
    HORMONE RESEARCH, 1992, 38 (1-2) : 84 - 89
  • [2] The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
    Liu, Xiaoshuang
    Tang, Chao
    Wen, Guodao
    Zhong, Chunyu
    Yang, Jin
    Zhu, Junhao
    Ma, Chiyuan
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9
  • [3] Experience with Dopamine Agonists in the Treatment of Prolactinomas
    Barabash, Nadiya Ye.
    Tykhonova, Tetiana M.
    ACTA MEDICA LITUANICA, 2022, 29 (02) : 311 - 317
  • [4] Dopamine agonists in prolactinomas: when to withdraw?
    Pedro Souteiro
    Sandra Belo
    Davide Carvalho
    Pituitary, 2020, 23 : 38 - 44
  • [5] Dopamine receptor agonists for treating prolactinomas
    Colao, A
    di Sarno, A
    Pivonello, R
    di Somma, C
    Lombardi, G
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (06) : 787 - 800
  • [6] Dopamine agonists in prolactinomas: when to withdraw?
    Souteiro, Pedro
    Belo, Sandra
    Carvalho, Davide
    PITUITARY, 2020, 23 (01) : 38 - 44
  • [7] Hypersexuality in men with prolactinomas treated with dopamine agonists
    Bancos, Irina
    Nippoldt, Todd B.
    Erickson, Dana
    ENDOCRINE, 2017, 56 (03) : 456 - 457
  • [8] Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment
    Shimon, Ilan
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (08)
  • [9] Dopamine Agonists Can Reduce Cystic Prolactinomas
    Faje, Alexander
    Chunharojrith, Paweena
    Nency, Joshipura
    Biller, Beverly M. K.
    Swearingen, Brooke
    Klibanski, Anne
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (10): : 3709 - 3715
  • [10] Hypersexuality in men with prolactinomas treated with dopamine agonists
    Irina Bancos
    Todd B. Nippoldt
    Dana Erickson
    Endocrine, 2017, 56 : 456 - 457